SHAWNA FURY: Open Payments
NPI 1942721584 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,492 in 69 payments from 17 companies in 2025. Trend: 2023 $622 · 2024 $785 · 2025 $1,492
Food & beverage: $1,492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $369 |
| Teva Pharmaceuticals USA, Inc. | 6 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $165 |
| Novo Nordisk Inc | 2 | $104 |
| Biogen, Inc. | 1 | $104 |
| Axsome Therapeutics, Inc. | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
Products named: VRAYLAR, AUSTEDO XR, CAPLYTA, ZURZUVAE, Auvelity, Ozempic, ABILIFY ASIMTUFII, COBENFY.
Industry payments across IA — which companies pay providers there.
